4D CT与甲氧基异丁基异腈SPECT/CT在原发性甲状旁腺功能亢进症中定位甲状旁腺腺瘤的诊断效能
单中心回顾性研究纳入400例原发性甲状旁腺功能亢进症患者,比较4D CT与甲氧基异丁基异腈SPECT/CT术前定位效能。4D CT联合SPECT/CT与单独4D CT诊断效能相似(AUC 0.88 vs 0.87,P=0.82),两者均优于SPECT/CT(AUC 0.78,P<0.001)。4D CT敏感度高于SPECT/CT(79.3% vs 58.0%,P<0.001),在单腺体病和多腺体病亚组中均更高。
要点
- 4D CT定位敏感度79.3%(414/522),高于甲氧基异丁基异腈SPECT/CT的58.0%(303/522),P<0.001。
- 4D CT联合SPECT/CT的AUC为0.88,单独4D CT为0.87,两者无显著差异(P=0.82)。
- 4D CT在单腺体病敏感度92.5%(297/321)vs SPECT/CT 75.1%(241/321);多腺体病58.2%(117/201)vs 30.8%(62/201),均P<0.001。
核心结论
- 4D CT在单腺体和多腺体病患者中术前定位均优于甲氧基异丁基异腈SPECT/CT。
- 4D CT联合SPECT/CT与单独4D CT相比未提高诊断效能。
研究设计与样本
- 单机构回顾性研究,纳入2013年2月至2016年5月期间接受甲氧基异丁基异腈SPECT/CT与4D CT(平扫、增强、动脉期和延迟静脉期)联合成像方案、并在6个月内行甲状旁腺切除术的原发性甲状旁腺功能亢进症患者400例(女319例,男81例;平均年龄61岁±14)。
- 参考标准为手术报告所示位置并经病理证实为甲状旁腺腺瘤或增生。
- 采用四象限分析比较各 modality 及联合应用的敏感度、特异度和AUC。
诊断标准与关键数值
- 4D CT联合SPECT/CT的AUC为0.88(95%CI:0.86,0.90),单独4D CT的AUC为0.87(95%CI:0.85,0.90),两者比较P=0.82。
- 甲氧基异丁基异腈SPECT/CT的AUC为0.78(95%CI:0.76,0.81),低于4D CT联合SPECT/CT和单独4D CT(均P<0.001)。
- 4D CT敏感度79.3%(414/522),甲氧基异丁基异腈SPECT/CT敏感度58.0%(303/522),P<0.001。
- 单腺体病亚组:4D CT敏感度92.5%(297/321),SPECT/CT敏感度75.1%(241/321),P<0.001。
- 多腺体病亚组:4D CT敏感度58.2%(117/201),SPECT/CT敏感度30.8%(62/201),P<0.001。
临床应用与阅片要点
- 4D CT在单腺体病和多腺体病中定位功能亢进的甲状旁腺均优于甲氧基异丁基异腈SPECT/CT。
- 4D CT联合甲氧基异丁基异腈SPECT/CT与单独4D CT相比未提高诊断效能。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background There currently is no consensus on the optimal localization procedure and imaging protocol for parathyroid adenoma. Parathyroid four-dimensional (4D) CT has emerged as a promising method for preoperative localization. Purpose To evaluate the diagnostic performance of parathyroid 4D CT and technetium 99m-sestamibi (hereafter, referred to as sestamibi) SPECT/CT in preoperative localization in patients with primary hyperparathyroidism. Materials and Methods This was a single-institution retrospective study of patients with primary hyperparathyroidism who underwent a combined imaging protocol of sestamibi SPECT/CT and 4D CT (noncontrast, contrast agent-enhanced, arterial, and delayed venous phases) acquired in a single setting from February 2013 to May 2016, with subsequent parathyroidectomy within 6 months. Reference standard for correct localization was on the basis of location denoted on operative reports, with pathologic confirmation of parathyroid adenoma or hyperplasia. By using a four-quadrant analysis, sensitivity, specificity, and area under the curve (AUC) for localization of the hyperfunctioning parathyroid gland or glands at sestamibi SPECT/CT and 4D CT were compared, per modality and in combination. Results Four hundred patients (319 women, 81 men; mean age, 61 years ± 14 [standard deviation]) were evaluated. Similar diagnostic performance was found in both combined 4D CT with sestamibi SPECT/CT and 4D CT alone (area under the curve [AUC], 0.88 [95% CI: 0.86, 0.90] and 0.87 [95% CI: 0.85, 0.90], respectively; P = .82). Both modalities outperformed sestamibi SPECT/CT (AUC, 0.78; 95% CI: 0.76, 0.81; P < .001). Four-dimensional CT showed higher sensitivity than did sestamibi SPECT/CT (sensitivity, 79.3% [414 of 522] vs 58.0% [303 of 522], respectively; P < .001). In a subset analysis, 4D CT had higher sensitivity than sestamibi SPECT/CT in patients with single-gland disease (sensitivity, 92.5% [297 of 321] vs 75.1% [241 of 321], respectively; P < .001) and with multigland disease (sensitivity, 58.2% [117 of 201] vs 30.8% [62 of 201], respectively; P < .001). Conclusion Four-dimensional CT provided superior preoperative localization compared with sestamibi SPECT/CT in patients with single and multigland disease. The combination of the two modalities did not improve diagnostic performance compared with four-dimensional CT alone. © RSNA, 2019 Online supplemental material is available for this article. See also the editorial by Sinha and Oates in this issue.
引用
- Yeh R, Tay YD, Tabacco G, et al. Diagnostic Performance of 4D CT and Sestamibi SPECT/CT in Localizing Parathyroid Adenomas in Primary Hyperparathyroidism. Radiology. 2019. PMID: 30835187. doi:10.1148/radiol.2019182122
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。